Clinical outcome in IL-10– and IL-10 receptor–deficient patients with or without hematopoietic stem cell transplantation
Open Access
- 31 March 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 131 (3), 825-830.e9
- https://doi.org/10.1016/j.jaci.2012.09.025
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and TherapyGastroenterology, 2012
- Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's diseaseGenes & Immunity, 2012
- Defective IL10 Signaling Defining a Subgroup of Patients With Inflammatory Bowel DiseaseAmerican Journal Of Gastroenterology, 2011
- Infant colitis—it's in the genesThe Lancet, 2010
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 ReceptorNew England Journal of Medicine, 2009
- A HomozygousCARD9Mutation in a Family with Susceptibility to Fungal InfectionsNew England Journal of Medicine, 2009
- Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndromeJournal of Allergy and Clinical Immunology, 2008
- Flowcytometric phenotyping of common variable immunodeficiencyCytometry Part B: Clinical Cytometry, 2008
- Mutation nomenclature extensions and suggestions to describe complex mutations: A discussionHuman Mutation, 1999
- Immunophenotyping of blood lymphocytes in childhoodReference values for lymphocyte subpopulationsThe Journal of Pediatrics, 1997